Jean Chia-Chun Chang

Title: The Innovative Mind of Jean Chia-Chun Chang

Introduction: Jean Chia-Chun Chang, based in Los Gatos, California, is an accomplished inventor recognized for his significant contributions in the field of biotechnology. With a focus on the development of co-stimulatory polypeptides, Chang’s work paves the way for advancements in therapeutic and gene therapy applications.

Latest Patents: Chang holds a patent for co-stimulatory polypeptides that provide novel polynucleotides and polypeptides. These innovations exhibit the ability to preferentially bind to CD28 or CTLA-4 receptors, enhancing or hampering T cell proliferation responses compared to the existing human B7-1. The polypeptides and polynucleotides from this invention offer promising applications in vaccines, gene therapy, and various treatment methods, showcasing their potential in medical science.

Career Highlights: Chang is associated with Maxygen, Inc., a company known for its focus on biological innovations. His work at the firm illustrates his commitment to advancing medical technology and making meaningful contributions in his field.

Collaborations: Throughout his career, Chang has collaborated with esteemed professionals, including Juha Punnonen and Alexandra L L Lazetic. These partnerships signify his ability to work alongside other talented individuals to further scientific research and development.

Conclusion: Jean Chia-Chun Chang stands out as a noteworthy inventor in the realm of biotechnology. His patent for co-stimulatory polypeptides reflects a significant stride in understanding and manipulating T cell responses, ultimately enhancing therapeutic and preventive measures in medicine. As innovations like these continue to emerge, Chang's work exemplifies the impact of dedicated research and collaboration in shaping the future of healthcare.